|
Post by avogadro on Sept 1, 2015 13:03:06 GMT -5
avogadro, Can't help wondering - what happened to the old "avogadro"? This is what they left of him. Actually I'm thinking of changing my name to ordagova, since I don't know if I'm coming or going.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 1, 2015 13:36:38 GMT -5
Avogadro: Thanks for your valiant attempt to lift the spirits of the committed long investors here. Anything new to add??? My reaction to your post: Other than that, Mrs. Lincoln, how was the play? Mrs. Lincoln...hilarious! There is 121mill shares of "remaining work" to be undone...now that is the major task I see at hand, with a combination now of a discipline group of INVESTORS, institutional holdings, and a volatile market that raises uncertainty for some valuations and future earnings of some large caps moving forward, I see a share price that looks very attractive given the fundamentals and technicals of this equity...the scripts building behind the insurance dam "wall" continues to rise...trust me it's there as I am one of them and know others as well...when it breaks it will make the levee breaking during Katrina look like a tropical storm for the "short sighted" ;) Maybe MNKD will re-set the bar for epic squeezes. We can only hope. NRx #s need to start to show some consistent week over week growth. Probably won't happen in Sept, but by October it needs to.
|
|
|
Post by mnholdem on Sept 1, 2015 13:59:45 GMT -5
Conspiracy theory du jour, courtesy of some old timer longs on ymb: Sanofi and Google are partnering in Diabetes monitoring.... Google probably knows Al Mann very well, since he is the engineering and business guru behind so many devices and therapies for diabetes. Ergo, the M in Google's new Alphabet just might be "Mannkind" at some level or another. And maybe just maybe, a CGM by Google would allow for remote monitoring by Google, with notifications about when to take a hit off the Dreamboat, and what dose to use (none of the arithmetic issues some new users have that way). Well? What do you think ?
I fell for the Sanofi-Medtronic buyout theory back when they signed their diabetes alliance. I don't think I'm going to place too much credence in this one between Sanofi and Google. That's what I think... um, though I have to admit I still think the Sanofi-Medtronic buying out Afrezza-Technosphere someday (or year) in the future has merit. But Google buying the Technosphere platform for future TS drugs seems to me to be a little out of their area of expertise, IMHO.
|
|
|
Post by daduke38 on Sept 1, 2015 14:10:47 GMT -5
Conspiracy theory du jour, courtesy of some old timer longs on ymb: Sanofi and Google are partnering in Diabetes monitoring.... Google probably knows Al Mann very well, since he is the engineering and business guru behind so many devices and therapies for diabetes. Ergo, the M in Google's new Alphabet just might be "Mannkind" at some level or another. And maybe just maybe, a CGM by Google would allow for remote monitoring by Google, with notifications about when to take a hit off the Dreamboat, and what dose to use (none of the arithmetic issues some new users have that way). Well? What do you think ? Conspiracy theory du jour is hilarious is what I think. But whatever get you through a MNKD day, I guess. I gave up months ago trying to figure out how this plays out. I just know Afrezza works and how we get there. I gave up trying to guess. But you watch, it will be something that nobody ever dreamed of.
|
|
|
Post by mssciguy on Sept 1, 2015 14:17:05 GMT -5
avogadro Maybe I could have been clearer with the question but here's an answer (wish I had some myself right now): https://www.reddit.com/r/theydidthemath/comments/2ja8y0/request_how_much_guacamole_could_i_make_with_a/
|
|